<DOC>
	<DOCNO>NCT00366483</DOCNO>
	<brief_summary>To assess safety , tolerability pharmacokinetics single multiple ascend oral dos lecozotan SR healthy young elderly subject .</brief_summary>
	<brief_title>Study Evaluating Safety Lecozotan SR Healthy Young Elderly Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Young subject : Men age 18 45 year . Elderly subject : Men woman ≥ 65 year age . Body mass index range 18 30 kg/m2 body weight ≥ 50 kg . Healthy determine investigator . History neuropsychiatric disorder . History drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>healthy young volunteer</keyword>
	<keyword>healthy elderly volunteer</keyword>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>5HT1A antagonist</keyword>
	<keyword>Health</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>